Company Profile · Healthcare

Mayinglong Pharmaceutical Group Co Ltd

600993 · Shanghai
Country
China
IPO date
Apr 23, 2004
Employees
2,544
Buffett Score
72/100
Strong
Market capCN¥9.71B
Revenue (TTM)CN¥3.93B
EBITDACN¥710.27M
Profit margin15.29%
ROE14.16%
P/E (TTM)16.2
Forward P/E23.42
EPSCN¥1.39
Dividend yield3.15%
52-week rangeCN¥21.22 – CN¥30.18

Data from EODHD, shown in the reporting currency; for reference only, not investment advice.

Mayinglong Pharmaceutical Group Co., Ltd., together with its subsidiaries, manufactures and sells Chinese and Western medicines in China and internationally. It operates through three segments: Pharmaceutical Manufacturing; Pharmaceutical Wholesale and Retail; and Medical Services. The company offers functional cosmetics, care products and food, Chinese herbal medicines, and medical devices. It also manufactures, processes, and sells pharmaceutical packaging materials, cosmetics, and Chinese medicines; produces and sells health food; and offers class I and II medical devices, machinery, household goods, electronic products, daily necessities, hygiene products, and disinfection products, as well as road freight transportation services. In addition, the company is involved in the retail and wholesale of medical devices and medicines; imports raw and auxiliary materials, machinery and equipment, instruments and meters, spare parts and related technologies; and exports its products. Mayinglong Pharmaceutical Group Co., Ltd. was founded in 1582 and is headquartered in Wuhan, China.

History

Coming soonThis section is being filled in — check back soon.

Industry position

Coming soonThis section is being filled in — check back soon.

No reports on this stock in your language yet.